Enoxacin cream

This product has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacilli. It has good antibacterial activity in vitro against the following bacteria: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. It often has antibacterial activity against multi-drug resistant bacteria. It has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing Haemophilus influenzae and Moraxella. It has antibacterial activity against most strains of Pseudomonas such as Pseudomonas aeruginosa. This product has antibacterial activity against methicillin-sensitive Staphylococcus aureus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus and Enterococcus faecalis. It has good antimicrobial activity against Chlamydia trachomatis, Mycoplasma, Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. The antibacterial activity against anaerobic bacteria is poor. Enoxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.

The main ingredient of this product is: Enoxacin. Its chemical name is: 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic acid sesquihydrate.

This product is a white or light yellow emulsion base ointment.

It is suitable for skin infectious diseases caused by sensitive pathogenic bacteria, such as purulent skin infections, impetigo, folliculitis, wound infections, paronychia, furunculosis, etc.

Local adverse reactions are rare. Long-term and large-scale use may also produce the same adverse reactions as systemic medication after absorption from the skin, such as: allergic reactions such as rash and skin itching, gastrointestinal reactions such as abdominal discomfort, diarrhea, nausea, central nervous system reactions such as dizziness and headache, and other reactions such as increased serum aminotransferase, increased blood urea nitrogen, and decreased peripheral blood white blood cells.

Patients who are allergic to this product and quinolones are prohibited from using this product. Pregnant women should not use it.

Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: Not yet clear.

Long-term and excessive use, after local absorption, may produce the same drug interactions as systemic medications, such as increasing the blood concentrations of drugs such as cyclosporine and probenecid, and interfering with the metabolism of caffeine.

Keep tightly closed in a cool, dry place.

10g:0.1g

24 months

Beijing Jingfeng Pharmaceutical (Shandong) Co., Ltd.

• Founded in:

  1994-03-14

• Address:

  No. 9 Jiuzhou Road, Boshan District, Zibo City, Shandong Province

• Tax NO.:

  913703041641044634

• Registered Funds:

  416.6098 million yuan

• Email:

  Log in to view